Figure 4.
Three cases of fragment-based drug discovery applications using ACFIS 2.0. (A) Design of a monoamine oxidas-B inhibitor for treating Parkinson's disease based on safinamide. (B) Design of a tropomyosin receptor kinase inhibitor for cancer therapies based on larotrectinib. (C) Design of a serotonin transporter inhibitor for treating depression based on vilazodone.